Andrey Korshunov Selected Research

Ependymoma

10/2021	Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.
1/2019	YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
1/2018	Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
1/2018	Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
9/2017	Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
1/2017	The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.
1/2017	Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.
9/2016	Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
1/2016	Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
8/2015	Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrey Korshunov Research Topics

Disease

110	Neoplasms (Cancer) 12/2022 - 01/2002
62	Medulloblastoma 01/2022 - 05/2004
20	Glioma (Gliomas) 12/2022 - 05/2008
20	Ependymoma 10/2021 - 07/2002
19	Astrocytoma (Pilocytic Astrocytoma) 12/2022 - 07/2002
17	Brain Neoplasms (Brain Tumor) 11/2021 - 12/2008
16	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 07/2002
11	Primitive Neuroectodermal Tumors (PNET) 11/2021 - 09/2007
9	Carcinogenesis 01/2020 - 11/2003
8	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2009
5	Oligodendroglioma 12/2022 - 01/2002
5	Disease Progression 01/2021 - 03/2009
4	Chromosome Aberrations (Chromosome Abnormalities) 11/2010 - 03/2007
3	Chromothripsis 12/2021 - 08/2012
3	Pinealoma (Pineoblastoma) 01/2020 - 08/2011
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 11/2014
3	Meningioma (Meningiomas) 01/2007 - 09/2002
2	Genomic Instability 12/2019 - 06/2016
2	Typical Teratoid Rhabdoid Tumor 01/2019 - 12/2012
2	Ganglioglioma 10/2018 - 01/2017
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2017 - 01/2016
2	Intellectual Disability (Idiocy) 11/2012 - 01/2012
1	Pleomorphic Adenoma 11/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 01/2021
1	Turcot syndrome 01/2021

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2002
22	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2005
20	Biological ProductsIBA 01/2021 - 07/2002
19	Biomarkers (Surrogate Marker)IBA 12/2022 - 07/2002
15	RNA (Ribonucleic Acid)IBA 11/2021 - 11/2003
14	Formaldehyde (Formol)FDA Link 12/2022 - 04/2011
14	ParaffinIBA 12/2022 - 06/2011
13	Messenger RNA (mRNA)IBA 01/2020 - 11/2003
12	Pharmaceutical PreparationsIBA 12/2021 - 01/2007
10	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2009
9	ChromatinIBA 12/2020 - 01/2012
7	Histones (Histone)IBA 12/2020 - 01/2012
4	ProteomeIBA 01/2022 - 10/2018
4	Phosphotransferases (Kinase)IBA 01/2020 - 01/2015
4	Small Interfering RNA (siRNA)IBA 01/2018 - 05/2008
3	NucleotidesIBA 11/2021 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 06/2011
3	AntibodiesIBA 01/2019 - 01/2002
3	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2017 - 12/2013
3	Histone Deacetylase InhibitorsIBA 12/2012 - 06/2010
3	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2003 - 01/2002
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2006
2	Indicators and Reagents (Reagents)IBA 01/2021 - 11/2012
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 11/2017
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020 - 11/2012
2	CateninsIBA 01/2019 - 11/2010
2	2,6-dinitrotoluene (DNT)IBA 01/2018 - 01/2017
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 08/2013
2	Dactinomycin (Actinomycin)FDA LinkGeneric 11/2017 - 09/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 11/2014
2	TenascinIBA 01/2017 - 07/2002
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 10/2014
2	NestinIBA 01/2016 - 11/2012
2	Lysine (L-Lysine)FDA Link 11/2014 - 03/2013
2	Sorafenib (BAY 43-9006)FDA Link 10/2014 - 08/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2014 - 11/2011
2	Proto-Oncogene Proteins B-rafIBA 11/2011 - 04/2011
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2010 - 12/2008
2	Codon (Codons)IBA 01/2010 - 12/2008
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2003 - 09/2002
2	Cyclin AIBA 09/2002 - 07/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2002 - 07/2002
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2002 - 01/2002
2	AntigensIBA 07/2002 - 07/2002
1	VimentinIBA 12/2022
1	sonidegibIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	CarbonIBA 12/2021
1	IonsIBA 12/2021
1	Retinaldehyde (Retinal)IBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Tricarboxylic AcidsIBA 10/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2021
1	Vardenafil Dihydrochloride (Levitra)FDA Link 01/2021
1	Thrombospondin 1IBA 01/2021
1	PLX5622IBA 01/2021
1	Arsenic Trioxide (Trisenox)FDA Link 01/2021
1	ManganeseIBA 01/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	acetyl- glycyl- valyl- allo- isoleucyl- seryl- glutaminyl- isoleucyl- arginyl- prolyl- cysteinamideIBA 01/2021
1	PeptidomimeticsIBA 01/2021
1	Arginine (L-Arginine)FDA Link 12/2020
1	Valine (L-Valine)FDA Link 12/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2020

Therapy/Procedure

50	Therapeutics 01/2022 - 12/2005
12	Drug Therapy (Chemotherapy) 01/2022 - 05/2004
9	Radiotherapy 12/2021 - 03/2004
5	Transplantation 01/2021 - 11/2011
2	Aftercare (After-Treatment) 01/2021 - 01/2016
2	Craniospinal Irradiation 01/2020 - 01/2016
2	Chemoradiotherapy 01/2016 - 03/2009
1	Heavy Ion Radiotherapy 12/2021
1	Cranial Irradiation 01/2021